---
$id: https://graph.org.ai/products/commodity/51111872
$type: Product
source: UNSPSC
code: "51111872"
title: "Zanoterone"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zanoterone

**UNSPSC Code**: 51111872
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-androgen with the molecular formula C23H32N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XQ5V1W49JG, chemically known as 1-(methylsulfonyl)-1h-5alpha,17alpha-pregn-20-yno(3,2-c)pyrazol-17-ol but generally known as zanoterone, which bears US NIH Compound Identifier 60180. European Medicines Agency schedules Zanoterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00139MIG. The term ZANOTERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ZANOTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zanoterone under HS 29372900 and SITC 54153. As of Q4 2014, ZANOTERONE remains the US FDA Preferred Term for this commodity. Zanoterone bears US NLM identifiers UMLS ID C0078493 and NCI Concept Code C74123. SMILES: S(=O)(=O)(N1NC2CC3C(C4C(C5C(CC4)(C(O)(CC5)C#C)C)CC3)(CC2C1)C)C.

